Cargando…
First clinical postmarketing experiences in the treatment of epilepsies with brivaracetam: a retrospective observational multicentre study
OBJECTIVES: Brivaracetam (BRV) is the latest approved antiepileptic drug and acts as a synaptic vesicle protein 2A ligand. The aim of the present study was to evaluate the efficacy and tolerability of BRV in the clinical setting. DESIGN: Retrospective, observational multicentre study. SETTING: We re...
Autores principales: | Menzler, Katja, Mross, Peter Michael, Rosenow, Felix, Schubert-Bast, Susanne, Willems, Laurent Maximilian, Zahnert, Felix, Immisch, Ilka, Fuest, Sven, von Podewils, Felix, Kunz, Rhina, Hirsch, Martin, Mueller, Tamara, Marquetand, Justus, Winter, Yaroslav, Langenbruch, Lisa, Cicanic, Michal, Beyenburg, Stefan, Strzelczyk, Adam, Knake, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858140/ https://www.ncbi.nlm.nih.gov/pubmed/31690606 http://dx.doi.org/10.1136/bmjopen-2019-030746 |
Ejemplares similares
-
Brivaracetam in the Treatment of Patients with Epilepsy—First Clinical Experiences
por: Zahnert, Felix, et al.
Publicado: (2018) -
Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From Germany
por: Willems, Laurent M., et al.
Publicado: (2018) -
Socioeconomic Outcome and Quality of Life in Adults after Status Epilepticus: A Multicenter, Longitudinal, Matched Case–Control Analysis from Germany
por: Kortland, Lena-Marie, et al.
Publicado: (2017) -
Brivaracetam substituting other antiepileptic treatments: Results of a retrospective study in German epilepsy centers
por: Lerche, Holger, et al.
Publicado: (2020) -
Efficacy, Tolerability, and Safety of Concentrated Intranasal Midazolam Spray as Emergency Medication in Epilepsy Patients During Video-EEG Monitoring
por: von Blomberg, Anemone, et al.
Publicado: (2020)